Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 46,940 | 30,648 | 7,559 | 4,000 | 2,577 |
| Gross Profit | 46,940 | 30,648 | 7,559 | 4,000 | 2,577 |
| Operating Expenses | 61,694 | 64,542 | 48,016 | 51,964 | 52,212 |
| Operating Income | -14,754 | -33,894 | -40,457 | -47,964 | -49,635 |
| Other Income | 108 | 177 | 87 | 104 | 172 |
| Pre-tax Income | -14,646 | -33,717 | -40,370 | -47,860 | -49,463 |
| Income Tax | N/A | N/A | N/A | 0 | -176 |
| Net Income Continuous | -14,646 | -33,717 | -40,370 | -47,860 | -49,287 |
| Net Income | $-14,646 | $-33,717 | $-40,370 | $-47,860 | $-49,287 |
| EPS Basic Total Ops | -0.41 | -1.24 | -2.30 | -4.30 | -4.62 |
| EPS Basic Continuous Ops | -0.41 | -1.24 | -2.23 | -4.06 | -4.61 |
| EPS Diluted Total Ops | -0.41 | -1.24 | -2.30 | -4.30 | -4.62 |
| EPS Diluted Continuous Ops | -0.41 | -1.24 | -2.23 | -4.06 | -4.61 |
| EBITDA(a) | $-14,264 | $-33,461 | $-39,866 | $-46,667 | $-47,735 |